|
BioForce
Nanosciences Holdings, Inc. Announces the Appointment of
Michael Dunham to Its Board of Directors
Other Topics:
Nanotechnology Research, Nanotech
Public Awareness
BioForce Nanosciences Holdings, Inc.
October 1, 2007
AMES, IA -- BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH),
a company focused on the development and commercialization of
nanotech tools and solutions for the life sciences, today
announced the appointment of Michael Dunham to its Board of
Directors. Mr. Dunham brings to BioForce his broad experience
in high technology companies, which includes previously
serving as a director for the nanotechnology company, Arryx
Technology. |
|
Mr.
Dunham is and has been involved with numerous public and
private company boards in a variety of industries, including
nanotechnology, financial services, software and
manufacturing. He has received recognition as 1995
Entrepreneur of the Year selected by Merrill Lynch/INC. and
was the CEO of a company that was included in INC. Magazine's
top 500 Companies two consecutive years.
Mr. Dunham is the Chairman and owner of WorkWise Inc. and
Intercim Inc., which specialize in software systems for
manufacturing companies. Previously, Mr. Dunham was the Senior
Vice President-Business Development for Industrial & Financial
Systems (IFS). He was also a co-founder and CEO of Effective
Management Systems, Inc., a Milwaukee-based public software
corporation that provided Enterprise Resource Planning (ERP)
and Manufacturing Execution Systems (MES) to over 1,600
customer locations in North America, Asia and Europe.
"The addition of Mike Dunham to the BioForce Nanosciences
Board adds tremendous experience and credibility to our focus
on continued excellence and innovation in the field of
nanotechnology," noted Dr. Eric Henderson, CEO of BioForce
Nanosciences Holdings, Inc. "His wealth of knowledge, passion,
and experience will be important in helping us achieve our
goals of continued expansion and commercialization as well as
continuing to establish a strong presence in the biotechnology
community," concluded Dr. Henderson.
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences develops and commercializes nanotech
tools and solutions for the life sciences. BioForce's flagship
product, the Nano eNabler(tm) molecular printer, gives the
Company a platform for development and discovery. BioForce
technology is being used in sensor functionalization;
patterning and cell adhesion; and printing proteins to guide
neural cell growth. For more information, visit
www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that
may be affected by certain risks and uncertainties, including
those risks and uncertainties described in BioForce
Nanosciences' most recent filings with the Securities and
Exchange Commission. BioForce Nanosciences' actual results
could differ materially from such forward-looking statements.
BioForce assumes no duty to update these statements at any
future date. |
